InvestorsHub Logo
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 6147

Tuesday, 03/16/2021 12:05:12 PM

Tuesday, March 16, 2021 12:05:12 PM

Post# of 6748
ABUS gets go-ahead to start phase-1 trial of AB-836, an HBV capsid inhibitor (a/k/a core inhibitor or CpAM):

https://finance.yahoo.com/news/arbutus-receives-regulatory-approval-initiate-113000540.html

ENTA and ASMB have compounds in the clinic from this class.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News